
Andexxa: Reported Serious Adverse Events
“Andexxa was an antidote for major bleeding complications caused by Xarelto and Eliquis, including intracerebral and intra-abdominal. While Andexxa stopped the bleeding, it was associated with a 2.1-fold increase in blood clots and a 2.8-fold increase in deaths compared with usual care,” states Greg Vigna, MD, JD, national pharmaceutical injury attorney. Click here to read the […]






